MDxHealth is trading at $0.64, down 5.43%, after falling from the September 17 close of $0.67; no clear company-specific catalyst has been identified for September 18, 2026.

  • No company-specific announcement, earnings update, regulatory action, or analyst catalyst has been identified.
  • Major U.S. indices are down less than 0.5%, offering no clear market-wide explanation for the move.